Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits

@inproceedings{SmithPalmer2015AchievingSV,
  title={Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits},
  author={Jayne Smith-Palmer and Karin H. Cerri and William J. Valentine},
  booktitle={BMC infectious diseases},
  year={2015}
}
BACKGROUND The goal of chronic hepatitis C treatment is to remove the virus to avoid progression of HCV-related disease. Sustained virologic response (SVR) is the most widely used efficacy endpoint in clinical studies of hepatitis C, and represents the eradication of HCV from the body. The aim of the current review was to examine the long-term clinical, economic and quality of life benefits associated with achieving SVR. METHODS A systematic literature review was performed using the PubMed… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 41 extracted citations

An economic assessment of contemporary kidney transplant practice.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons • 2018

References

Publications referenced by this paper.
Showing 1-10 of 101 references

A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2013
View 4 Excerpts
Highly Influenced

Hepatocarcinogenesis after SVR by interferon therapy in chronic hepatitis C patients [abstract

M Sasaki, K Yoshida, +3 authors R Narita
Journal of Gastroenterology and Hepatology. Asian Pacific Digestive Week 2011 Singapore • 2011
View 4 Excerpts
Highly Influenced

A cost-effectiveness analysis of telaprevir versus boceprevir in the treatment of hepatitis C: A greek national health system perspective [abstract

J Yfantopoulos, K Paparouni, ER. D’Angelo
Berlin Germany: ISPOR 15th Annual European Congress; • 2012
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…